Sun Pharma Share Price Target: Emkay Sets the Target Of Rs 2,400 – Here’s Why

The US Court of Appeals has vacated a preliminary injunction that had stalled Sun Pharma’s launch of Leqselvi in the U.S., a move analysts see as a key positive for the company. Emkay Global Financial Services has maintained its ‘BUY’ rating with a target price of Rs 2,400, citin

Read More

  • Related Posts

    NCLT Set to Rule on SpiceJet’s Rs 500-Crore Insolvency Battle Today After Lessor Fury

    The National Company Law Tribunal (NCLT) is set to pronounce its verdict on Wednesday in an insolvency petition filed against SpiceJet, in a case that has already drawn a rare rebuke from the bench over the airline’s handling of settlement talks with its creditors.A special bench Read More

    India’s Food Safety Crackdown Intensifies: Restaurants, Quick-Commerce Warehouses, Food Makers Face Action Over Hygiene Violations, Adulteration, Misleading Labels and Expired Stock

    India’s food regulatory bodies have tightened enforcement across India’s food and beverage sector, from labelling standards for spirits makers to hygiene compliance for restaurants and delivery platforms. Several hotels and eateries have been subjected to temporary closure across Read More

    Leave a Reply

    Your email address will not be published. Required fields are marked *